Zhongjing Wanxi Pharmaceutical Co., Ltd. was established in 1978 in Xixia County, Nanyang, the hometown of Zhang Zhongjing, the sage of traditional Chinese medicine, located at the southern foot of the 400-km-long Funiu Mountains. For decades, guided by the social commitment to “Assure the doctors, Comfort the customers, Reassure our ancestors” and its pharmaceutical philosophy that “Choice herbs, Choice medicine”, the company has established six major Chinese medicinal herb bases across three provinces and six regions, and has implemented industrialized cultivation and large‑scale production of medicinal materials to ensure product quality at the source. The company has built an advanced, fully automatic production base for concentrated Chinese medicine pills, and has established a National Enterprise Technology Center, Key Research Laboratory of Zhang Zhongjing Classic Prescriptions of TCM, and a Post-Doctoral Research Center. It holds 83 national invention patents and has developed 9 state-level new drugs. Its main products include more than 100 classic prescriptions under the “Zhongjing” brand — such as Liu Wei Di Huang Pills, Xiao Yao Pills, and Pi Pa Qing Fei Yin Granules — as well as innovative medicines including Zhongjing Tian Zhi Granules, Tai Zi Jin Granules, and “Yueyueshu” Tong Jing Bao Granules.

The company also produces over 500 kinds of Chinese medicinal slices and more than 300 types of Chinese medicine formula granules. It has nurtured nationally renowned trademarks such as “Zhongjing,” “Yueyueshu,” and “Feilong.” Among them, “Zhongjing” has been recognized as a China Time-Honored Brand and listed among the “Top 500 Chinese Trademarks.” The company has received numerous honors, including National Advanced Primary-Level Party Organization, National Model Unit for Ethnic Unity and Progress, National Advanced Private Enterprise in the “Ten Thousand Enterprises Help Ten Thousand Villages” Precision Poverty Alleviation Initiative, and National Advanced Private Enterprise in the Fight Against the COVID-19 Pandemic.

With a mission to contribute to the “Healthy China” initiative, Zhongjing Wanxi Pharmaceutical Co., Ltd. has developed a comprehensive, seven‑in‑one health industry integrating industry, agriculture, commerce, food, medicine, health, and hygienic materials. It has developed into a diversified enterprise group encompassing Zhongjing health care, Feilong Automotive Components, and Fortune, Health, Tourism, Real Estate, with two listed companies and over 20,000 employees.

The company is a national high-tech enterprise with an independent R & D center and more than 30 full-time R & D technicians. It has in-depth cooperation with many domestic agricultural and pharmaceutical colleges, such as Lafat of Hungary, South Korea Natural Biology, China Agricultural University, Beijing University of traditional Chinese Medicine and so on.